Gisens Biotech - Lightning Pitch

Why It Matters

Remote, continuous monitoring of heart and kidney health can dramatically cut hospitalizations and costs, while giving physicians the data needed to intervene earlier, fundamentally improving chronic disease care.

Key Takeaways

• Founder’s personal loss drives mission to monitor cardiovascular and kidney disease
• Gisens Biotech created home‑monitoring device for chronic heart and kidney patients
• Device aims to empower physicians with real‑time data outside clinics
• Remote monitoring promises earlier interventions and reduced hospital readmissions
• Founder invites collaboration, citing multiple lives already improved

Summary

In a concise lightning pitch, the founder of Gisens Biotech shares a deeply personal motivation: losing both parents to cardiovascular and chronic kidney disease. This tragedy spurred the creation of a home‑monitoring device designed to track patients with these conditions, aiming to give physicians actionable data beyond the clinic walls. The device captures key cardiovascular and renal metrics in real time, transmitting them to clinicians for early intervention. By shifting monitoring from hospitals to patients’ homes, Gisens hopes to reduce readmissions, lower treatment costs, and improve outcomes for a growing chronic‑disease population. The founder emphasizes the emotional stakes, stating, “I couldn’t do anything about my parents’ deaths, so I built a tool to prevent that for others.” He claims the technology has already changed multiple lives, including his own, and urges stakeholders to discuss partnership opportunities. If adopted widely, this platform could reshape chronic disease management, offering scalable telehealth solutions that empower both doctors and patients while opening a sizable market for remote‑monitoring technologies.